Now Playing
News|Videos|June 19, 2024
Case Study: 63-Year-Old Man With Multiple Myeloma
A team of multiple myeloma experts review a patient profile, offering preliminary insights and underscoring the importance of advanced practice providers in optimizing patient care.
Advertisement
Episodes in this series
Advertisement
Related to this article
At the 2026 National Summit on Hematologic Cancers, Kate Kennedy, MSN, APRN, flagged decisions where guidelines give nurses and APPs little direction.
Kate Kennedy, MSN, APRN, explains how Vanderbilt-Ingram's award-winning APP clinic moved bispecific step-up dosing out of the hospital.
Experts detail evidence for exercise, acupuncture, and mind-body care during radiation, and the knowledge and referral gaps that limit uptake.
The PCR-based tissue assay can now identify patients with MSI-high solid tumors who may be candidates for pembrolizumab.
An 18-year analysis of a foundation program found trial-related travel, lodging, and caregiving costs varied by income, distance, and trial phase.
Coral Omene, MD, PhD, discusses the clinical impact of breast cancer disparities and how oncology nurses can support diverse trial recruitment.
Jessica Miles, MS, RN, CNS, explains how bench testing showed pumps and filters did not compromise stem cell infusion safety.
The oral CSF-1R inhibitor produced a 54% response rate vs 3% with placebo at week 25 in the phase 3 MANEUVER trial.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves MSI Companion Diagnostic for Pembrolizumab in MSI-H Tumors
2
How a Nurse's Question Changed Stem Cell Infusion Practice at UC Davis
3
Cancer Trial Participants Reimbursed a Median $2,128 for Nonmedical Costs
4
Improving Clinical Trial Representation for Black Patients With Breast Cancer
5